Cargando…

Identification of a novel functional JAK1 S646P mutation in acute lymphoblastic leukemia

The survival rate of childhood acute lymphoblastic leukemia (ALL) is approaching 90%, while the prognosis of adults remains poor due to the limited therapeutic approaches. In order to identify new targets for ALL, we performed whole-exome sequencing on four adults with B-ALL and discovered a somatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qian, Li, Botao, Hu, Liangding, Ning, Hongmei, Jiang, Min, Wang, Danhong, Liu, Tingting, Zhang, Bin, Chen, Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471003/ https://www.ncbi.nlm.nih.gov/pubmed/28410228 http://dx.doi.org/10.18632/oncotarget.16670

Ejemplares similares

Granulocyte Colony-stimulating Factor-primed Bone Marrow: An Excellent Stem-cell Source for Transplantation in Acute Myelocytic Leukemia and Chronic Myelocytic Leukemia
por: Li, Yuhang, et al.
Publicado: (2015)

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
por: Flex, Elisabetta, et al.
Publicado: (2008)

Acquired JAK2 mutations confer resistance to JAK inhibitors in cell models of acute lymphoblastic leukemia
por: Downes, Charlotte E. J., et al.
Publicado: (2021)

CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report
por: Sun, Yao, et al.
Publicado: (2021)

JAK3 Mutations and Mitochondrial Apoptosis Resistance in T-Cell Acute Lymphoblastic Leukemia
por: Bodaar, Kimberly, et al.
Publicado: (2022)

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015)

Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD
por: Yao, Sun, et al.
Publicado: (2021)

PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression
por: Yuan, Shengnan, et al.
Publicado: (2021)

JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias
por: Kim, Sang-Kyu, et al.
Publicado: (2018)

JAK3 mutations and HOXA9 expression are important cooperating events in T-cell acute lymphoblastic leukemia
por: de Bock, Charles E., et al.
Publicado: (2018)

JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility
por: Lin, Minhui, et al.
Publicado: (2019)

JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia
por: Steeghs, Elisabeth M.P., et al.
Publicado: (2017)

Effects of NRAS Mutations on Leukemogenesis and Targeting of Children With Acute Lymphoblastic Leukemia
por: Qian, Jiabi, et al.
Publicado: (2022)

Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With FUS-ERG+ AML
por: Yao, Sun, et al.
Publicado: (2019)

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development
por: Roncero, A M, et al.
Publicado: (2016)

P319: IL7-RECEPTOR EXPRESSION IS FREQUENT IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND PREDICTS SENSITIVITY TO JAK-INHIBITION
por: Courtois, Lucien, et al.
Publicado: (2023)

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia
por: Wang, Huafeng, et al.
Publicado: (2022)

JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies
por: Downes, Charlotte EJ., et al.
Publicado: (2022)

Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia
por: Yoo, Jae Won, et al.
Publicado: (2022)

Epigenetic silencing of SOCS5 potentiates JAK‐STAT signaling and progression of T‐cell acute lymphoblastic leukemia
por: Sharma, Nitesh D., et al.
Publicado: (2019)

The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring‐Opitz Syndrome
por: Urreizti, Roser, et al.
Publicado: (2018)

PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010)

Mutational profiling of acute lymphoblastic leukemia with testicular relapse
por: Ding, Ling-Wen, et al.
Publicado: (2017)

Identification of novel lncRNAs involved in the pathogenesis of childhood acute lymphoblastic leukemia
por: Li, Sheng, et al.
Publicado: (2019)

Characterization and identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
por: Trentin, Luca, et al.
Publicado: (2014)

Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia
por: Lin, Chunlan, et al.
Publicado: (2012)

Identification of Interconnected Markers for T-Cell Acute Lymphoblastic Leukemia
por: Guven Maiorov, Emine, et al.
Publicado: (2013)

Discovery and identification of potential biomarkers of pediatric Acute Lymphoblastic Leukemia
por: Shi, Linan, et al.
Publicado: (2009)

Identification of somatic and germline mutations using whole exome sequencing of congenital acute lymphoblastic leukemia
por: Chang, Vivian Y, et al.
Publicado: (2013)

JAK2-negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with JAK2 mutation with literature review
por: Ogasawara, Toshie, et al.
Publicado: (2020)

Failure of tofacitinib to achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations
por: Wong, Jonathan, et al.
Publicado: (2020)

Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing
por: Yin, Hua, et al.
Publicado: (2022)

Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia
por: Zhang, JinFang, et al.
Publicado: (2022)

Identification of STRBP as a Novel JAK2 Fusion Partner Gene in a Young Adult With Philadelphia Chromosome-Like B-Lymphoblastic Leukemia
por: Zhang, Xin-Yue, et al.
Publicado: (2021)

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia
por: Degryse, S, et al.
Publicado: (2018)

Identification of RNPC3 as a novel JAK2 fusion partner gene in B‐acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib
por: Chen, Xue, et al.
Publicado: (2019)

The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia
por: Xu, Yan, et al.
Publicado: (2022)

FAT1 expression and mutations in adult acute lymphoblastic leukemia
por: Neumann, M, et al.
Publicado: (2014)

Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia
por: Langabeer, Stephen E., et al.
Publicado: (2016)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_29691djupvld8llnk32bk7g17h